“…Enlargement of the pulmonary arteries as detected by contrast‐enhanced computed tomography pulmonary angiography (CTPA) provides prognostic information in patients with various forms of cardiopulmonary disease. Enlargement of the pulmonary artery diameter (PAd) or increased ratio of the PAd to aorta diameter (PA:AA) has been associated with increased mortality in patients with chronic obstructive pulmonary disease (COPD), 1 , 2 interstitial lung disease, 3 , 4 , 5 pulmonary arterial hypertension (PAH), 6 , 7 chronic thromboembolic pulmonary hypertension (CTEPH), 7 , 8 chronic systolic heart failure, 9 and severe COVID‐19 infection. 10 This is not surprising, as pulmonary artery enlargement on CTPA has been shown to correlate with other better defined assessments of pulmonary hypertension, including echocardiography and right heart catheterization, 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 and the presence of pulmonary hypertension is associated with a poor prognosis in many of these conditions.…”